some drug are moneymakers. lots of people can take them. viagra was that or now ozempic etc. but there's lots of novel drugs that never get past testing because they cost too much or the market too small to recover profit.

these studies struggle to find candidates, the testers rarely have serious side effects, so i think on the net this will not cause the harm you worry.

however! i would be worried taking new broad market drugs post any fda collapse.. but there's fewer of those on average. and pharma companies compete on efficacy and side effects and love to show investors results. so mixed bag.

we play it too safe. ozempic will save many many lives. if it had been approved years earlier it would have saved many many more. waiting for perfect is what the current system feels like, and seems like something you also know is foolish.

18 studies. only 6 novel. not a healthy ecosystem imo

More of your "lots", "rarely", "fewer"... but zero actual data at all. Two large posts of your opinion, and no information to back it up.